<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: CYCC News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=cycc</link><description>Latest Financial News for Cyclacel Pharmaceuticals, Inc.</description><language>en-us</language><lastBuildDate>Tue, 15 Dec 2009 22:16:53 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Cyclacel receives delisting notice from Nasdaq (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_cyclacel_delisting_notice.html?.v=2</link><description>Cyclacel Pharmaceuticals Inc. said Tuesday its shares could be delisted from Nasdaq because the company does not comply with the exchange&apos;s $10 million minimum shareholder equity requirement.</description><guid isPermaLink="false">yahoo_finance/2564496162</guid><pubDate>Tue, 15 Dec 2009 22:16:53 Etc/GMT</pubDate></item><item><title>CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/cycc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3112729228</guid><pubDate>Tue, 15 Dec 2009 21:45:26 Etc/GMT</pubDate></item><item><title>Cyclacel Receives NASDAQ Notice of Non-Compliance (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180358.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. today announced that, on December 9, 2009, the Company was notified by the NASDAQ Staff that the Company does not comply with the minimum $10 million stockholders&apos; equity requirement set forth in NASDAQ Listing Rule 5450 and that the Company&apos;s securities are subject to delisting from The Nasdaq Global Market unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel .</description><guid isPermaLink="false">yahoo_finance/3255156037</guid><pubDate>Tue, 15 Dec 2009 21:05:00 Etc/GMT</pubDate></item><item><title>CardioNet, Cyclacel: Midday Volume Plays (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1302blag1/*http%3A//www.thestreet.com/_yahoo/story/10646449/1/cardionet-cyclacel-midday-volume-plays.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/629864159</guid><pubDate>Tue, 15 Dec 2009 19:29:27 Etc/GMT</pubDate></item><item><title>Cyclacel Provides Update on Meeting With FDA to Discuss Pivotal Study Design for Sapacitabine (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180311.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. announced today that the Company recently held a Type A meeting with the U.S. Food and Drug Administration to discuss a randomized Phase 3 study design for Cyclacel&apos;s oral sapacitabine capsules in acute myeloid leukemia and separately in myelodysplastic syndromes .</description><guid isPermaLink="false">yahoo_finance/4011706580</guid><pubDate>Tue, 15 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Stock Watch: BeaconEquity.com Issues Video Market Alert for Cyclacel Pharmaceuticals Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091214/180222.html?.v=1</link><description>DALLAS -- BeaconEquity.com announces a video investment report featuring Cyclacel Pharmaceuticals Inc. . The video report includes technical analysis, commentary, and industry information you need to know to make an educated investment decision.</description><guid isPermaLink="false">yahoo_finance/140768944</guid><pubDate>Mon, 14 Dec 2009 11:50:00 Etc/GMT</pubDate></item><item><title>Skymark Research Initiates Independent Research Coverage on Cyclacel Pharmaceuticals, Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091211/180101.html?.v=1</link><description>CALGARY, Alberta -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Cyclacel Pharmaceuticals, Inc. . Skymark Research is currently offering a complimentary trial subscription.</description><guid isPermaLink="false">yahoo_finance/4035541261</guid><pubDate>Fri, 11 Dec 2009 14:00:00 Etc/GMT</pubDate></item><item><title>Graft-Versus-Host Disease: Failures and Future Opportunities (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1366sud2h/*http%3A//seekingalpha.com/article/177492-graft-versus-host-disease-failures-and-future-opportunities?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2921595758</guid><pubDate>Thu, 10 Dec 2009 09:55:52 Etc/GMT</pubDate></item><item><title>Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091205/179744.html?.v=1</link><description>BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in elderly patients with acute myeloid leukemia and separately interim response data in myelodysplastic syndromes .</description><guid isPermaLink="false">yahoo_finance/763018443</guid><pubDate>Sat, 5 Dec 2009 15:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel to Host Conference Call on Monday, December 7 to Discuss New Phase 2 Sapacitabine Data to be Presented at ASH (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091201/179420.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2381622062</guid><pubDate>Tue, 1 Dec 2009 17:00:00 Etc/GMT</pubDate></item><item><title>Sapacitabine Phase 1 Data Published in Acute Leukemia and Myelodysplastic Syndromes (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091130/179269.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/95985736</guid><pubDate>Mon, 30 Nov 2009 14:00:00 Etc/GMT</pubDate></item><item><title>13 Biotechs to Watch for at Hematology Conference (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12skkejhu/*http%3A//seekingalpha.com/article/175681-13-biotechs-to-watch-for-at-hematology-conference?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2148786770</guid><pubDate>Mon, 30 Nov 2009 09:47:38 Etc/GMT</pubDate></item><item><title>CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091125/cycc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4162987934</guid><pubDate>Wed, 25 Nov 2009 21:17:12 Etc/GMT</pubDate></item><item><title>NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091120/20091120005709.html?.v=1</link><description>NEW YORK----The New York Society of Security Analysts will present the 13th Annual Biotech and Specialty Pharmaceuticals Conference on December 1, 2009.</description><guid isPermaLink="false">yahoo_finance/3791627478</guid><pubDate>Fri, 20 Nov 2009 20:02:00 Etc/GMT</pubDate></item><item><title>CYCLACEL PHARMACEUTICALS, INC. Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=cycc</link><description></description><guid isPermaLink="false">yahoo_finance/549237046</guid><pubDate>Wed, 18 Nov 2009 14:04:48 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals to Present Sapacitabine Phase 2 AML &amp; MDS Data at the Upcoming American Society of Hematology Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178570.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4152019729</guid><pubDate>Tue, 17 Nov 2009 12:00:00 Etc/GMT</pubDate></item><item><title>[$$] Biotech Stock Mailbag: Cardium Therapeutics (at RealMoney by TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmpe/rss/SIG=122ikugpr/*http%3A//www.thestreet.com/p/_yahoo/rmoney/biotech/10625964.html?cm_ven=YAHOO&amp;cm_cat=PREMIUM&amp;cm_ite=003190</link><description></description><guid isPermaLink="false">yahoo_finance/3377138371</guid><pubDate>Fri, 13 Nov 2009 10:00:29 Etc/GMT</pubDate></item><item><title>CYCLACEL PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/cycc10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3565414773</guid><pubDate>Thu, 12 Nov 2009 20:23:53 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for Cyclacel Pharmaceuticals, Inc. (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/c/cycc.html</link><description></description><guid isPermaLink="false">yahoo_finance/1642376144</guid><pubDate>Wed, 4 Nov 2009 14:28:56 Etc/GMT</pubDate></item><item><title>CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091103/cycc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/949823858</guid><pubDate>Tue, 3 Nov 2009 21:12:28 Etc/GMT</pubDate></item></channel></rss><!-- c19.finance.sp2.yahoo.com compressed/chunked Wed Dec 23 07:23:35 PST 2009 -->
